Home - Boston Life Sciences Times

LATEST ARTICLES

Public Health

56.13% of people in Delhi developed antibodies

Life Sciences Times - February 2, 20210

Pharma

Pfizer-BioNTech to produce 2 billion doses of Covid vaccine in 2021

Life Sciences Times - February 2, 20210

Life Sciences

Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China

Life Sciences Times - February 1, 20210

Pharma

Moleculin Signs Agreement with Catalyst Clinical Research to Begin Sarcoma Trial

Life Sciences Times - February 1, 20210

Pharma

Fractyl Announces Publication of Clinical Results from INSPIRE Study Showing Durable Insulin-Free Glycemic Control in Majority of Patients Treated

Life Sciences Times - February 1, 20210

Biotech

MOMA Therapeutics Appoints Asit Parikh as President and Chief Executive Officer

Life Sciences Times - February 1, 20210

Real Estate

IQHQ Expands Leadership Team to Support Rapid Growth of Life Sciences Commercial Real Estate Portfolio

Life Sciences Times - February 1, 20210

Public Health

US CDC makes masks mandatory on planes, public transportation

Life Sciences Times - February 1, 20210

Public Health

US Covid-19 cases, hospitalizations drop, deaths still spike

Life Sciences Times - February 1, 20210

Medtech

This alternative surgery may prevent total knee replacement

Life Sciences Times - February 1, 20210

1...835836837...856 Page 836 of 856

Heartseed Doses First Patient in Trial of Catheter-Delivered iPSC-Derived Cardiomyocyte Spheroids

June 12, 2026

Cepheid Donates Hemorrhagic Fever Tests to Support Ebola Bundibugyo Outbreak Response in Africa

June 12, 2026

Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL for Cataract Patients

June 11, 2026

N-Zyme Biomedical Begins Phase 2 Trial of Pepsin Inhibitor for Reflux Disease

June 11, 2026

Most Popular

Heartseed Doses First Patient in Trial of Catheter-Delivered iPSC-Derived Cardiomyocyte Spheroids

Cepheid Donates Hemorrhagic Fever Tests to Support Ebola Bundibugyo Outbreak Response in Africa

Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL for Cataract Patients

N-Zyme Biomedical Begins Phase 2 Trial of Pepsin Inhibitor for Reflux Disease

Recent Comments

EDITOR PICKS

Vertex Reports CASGEVY Data in Children Ages 5 to 11, Announces Additional Regulatory Submissions

Dana-Farber Receives $50 Million Grant From Yawkey Foundation for Planned Cancer Hospital

AdvanCell Expands Executive Team to Support U.S. Growth

THIS WEEK'S STORIES

Quanterix Appoints Jason Faessler as Chief Financial Officer

Cepheid Donates Hemorrhagic Fever Tests to Support Ebola Bundibugyo Outbreak Response in Africa

FDA Accepts Takeda Application for Pediatric ENTYVIO in Ulcerative Colitis and Crohn’s Disease

POPULAR CATEGORY

ABOUT US

FOLLOW US